Justin Arnall, PharmD, discusses the clinical significance of his research and case study on, “Loss of Pregnancy in a Patient with Chronic Myeloid Leukemia During Treatment with Nilotinib.”
Related Items
JHOP - October 2026 Vol 16, No 5 published on September 21, 2026 in Original Research, Adverse Events, Transplant, Drug Resistance, Oncology Pharmacy Programs/Protocols
JHOP - October 2026 Vol 16, No 5 published on September 21, 2026 in Original Research, Adverse Events, Disparities in Oncology Care, Dose Escalation/Reduction, Immunotherapy, Multiple Myeloma
JHOP - October 2026 Vol 16, No 5 published on September 21, 2026 in Original Research, Lymphoma, Methotrexate, Chemotherapy